Ultiva

Active Ingredient(s): Remifentanil
FDA Approved: * July 12, 1996
Pharm Company: * ABBOTT
Category: Pain Relief

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ultiva Overview

Remifentanil is a potent, short-acting synthetic opioid analgesic drug. It is given to patients during surgery to relieve pain and as an adjunct to an anaesthetic. Remifentanil is used for sedation as well as combined with other medications for use in general anesthesia. The use of remifentanil has made possible the use of high-dose opioid and low-dose hypnotic anesthesia, due to synergism between remifentanil and various hypnotic drugs and volatile anesthetics. Contents 1 Clinical use...

Read more Ultiva Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Remifentanil

Recent Ultiva Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Remifentanil
  • Injection: 1mg, 1mg/vial, 2mg, 2mg/vial, 5mg, 5mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ultiva: (1 result)

Sorted by National Drug Code
  • 67457-198 Ultiva 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC

Other drugs which contain Remifentanil or a similar ingredient: (1 result)